Other Industry News

RepliCel Life Sciences Announces Closing of Brokered and Non-brokered Private Placement

, a clinical stage regenerative medicine company focused on the development of autologous cell therapies, is pleased to announce that it has completed its financing announced on February 7, 2017, which consi... Full Story

Resverlogix Reports Positive FDA Type B Meeting on Design Issues Relating to a Proposed Phase 2a Kidney Dialysis Trial

today announced the receipt of the final minutes of an in-person Type B meeting with the Cardiovascular and Renal Products Division of the U.S. Food and Drug Administration (FDA). The purpose of the meeting ... Full Story

Takeover activity set to pick up this year

Chinese private equity and venture capital-led merger and acquisition activities will be more active in 2017 after their deal value set a new record in 2016, according to a report issued on Thursday by P... Full Story

China updates key drug list in boost for Big Pharma

China has updated list of medicines covered by basic medical insurance schemes, a long-awaited fillip for drugmakers in the world's second-largest drug market where many new drugs have been kept out of p... Full Story

Fudan-Zhangjiang Bio-Pharma Invests $2 Million in Adgero of the US

Shanghai Fudan-Zhangjiang Bio-Pharma invested $2 million into Adgero Biopharma of New Jersey. Adgero is developing a photodynamic therapy platform to treat cancer indications. PDT uses light sensitive co... Full Story

Matrix Joins $28M Series B In Chinese App For Children And Women's Healthcare

Matrix Partners China, Qiming Venture Partners and IDG Capital have invested RMB200 million (US$28 million) in a series B round in Anxin Doctor, a Beijing-based mobile health app focused on children and wome... Full Story

CohBar, Inc. Announces Positive Results from Preclinical NASH Study of its Lead Drug Candidates

, a preclinical stage biotechnology company focused on developing mitochondria based therapeutics (MBTs) to treat age-related diseases, announced today that it has completed a study to evaluate the potential... Full Story

Hong Kong's Ally Bridge Invests in Two European Biopharmas

Ally Bridge Group announced it has made investments in two European biopharmas: Galenica AG of Switzerland, and Nabriva , an Austrian-US pharma. Galenica's subsidiary Vifor Pharma, makes iron supplem... Full Story

BioSense Inks $68 Million Deal for Neovacs’ Autoimmune Disease Vaccine in China

New Jersey/Suzhou-based BioSense Global has signed an option agreement with Neovacs of France for Neovacs' Phase II-stage IFNα Kinoid therapeutic vaccine candidate, a treatment for lupus and dermat... Full Story

China to slash drug distribution groups in price drive

A state initiative to reduce intermediaries in China’s pharmaceutical market is expected to more than halve the number of companies in the sector, but experts say the government will struggle to achiev... Full Story


Company Search

Upcoming Events More